Baker Avenue Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-387
Closed -$39.4K 1118
2023
Q3
$39.4K Sell
387
-60
-13% -$6.09K ﹤0.01% 555
2023
Q2
$45.1K Buy
447
+16
+4% +$1.6K ﹤0.01% 541
2023
Q1
$39.6K Sell
431
-29
-6% -$2.53K ﹤0.01% 564
2022
Q4
$41.7K Buy
+460
New +$38.7K ﹤0.01% 518
2022
Q2
Sell
-4,356
Closed -$382K 319
2022
Q1
$382K Buy
4,356
+956
+28% +$82.8K 0.02% 245
2021
Q4
$297K Buy
3,400
+246
+8% +$20.4K 0.01% 267
2021
Q3
$257K Buy
+3,154
New +$284K 0.01% 228
2015
Q4
Sell
-41,396
Closed -$3.41M 200
2015
Q3
$3.41M Sell
41,396
-1,310
-3% -$117K 0.6% 48
2015
Q2
$3.76M Sell
42,706
-3,751
-8% -$344K 0.5% 66
2015
Q1
$4.11M Sell
46,457
-1,182
-2% -$105K 0.54% 51
2014
Q4
$3.96M Sell
47,639
-2,023
-4% -$168K 0.55% 51
2014
Q3
$4.19M Buy
49,662
+106
+0.2% +$8.58K 0.59% 40
2014
Q2
$4.02M Buy
49,556
+530
+1% +$41.7K 0.58% 41
2014
Q1
$3.73M Buy
49,026
+1,629
+3% +$119K 0.63% 41
2013
Q4
$3.41M Buy
47,397
+1,010
+2% +$70.2K 0.66% 41
2013
Q3
$3.19M Buy
+46,387
New +$3.07M 0.67% 43

Other funds holding NVS